SCHEMBL13056285

SCHEMBL13056285

Cc1cc(C)c(-c2cc(-c3ccccc3C(F)(F)F)c(-c3c(C)cc(C)c(-c4cccnc4)c3C)cc2-c2ccccc2C(F)(F)F)c(C)c1-c1cccnc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPY5R Q15761 1/20 0.48
▸ TRPA1 O75762 2/20 0.41
▸ SCN9A Q15858 2/20 0.41
▸ TRPM8 Q7Z2W7 1/20 0.41
▸ TRPV1 Q8NER1 1/20 0.41
▸ SLC22A12 Q96S37 1/20 0.40
▸ HSD11B1 P28845 3/20 0.39
▸ SCN5A Q14524 1/20 0.39
▸ CYP3A4 P08684 3/20 0.39
▸ CYP2D6 P10635 3/20 0.39
▸ CYP2C19 P33261 3/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ S1PR1 P21453 1/20 0.39
▸ CFTR P13569 1/20 0.39
▸ PDK2 Q15119 2/20 0.39
▸ CYP11B1 P15538 1/20 0.38
▸ CYP11B2 P19099 1/20 0.38
▸ USP1 O94782 1/20 0.38
▸ WDR48 Q8TAF3 1/20 0.38
▸ ALOX15 P16050 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12999238 0.96 NPY5R (0.46) NPY5RTRPA1SCN9ATRPM8TRPV1
SCHEMBL13056283 0.87 HSD11B1 (0.44) TRPA1SCN9ATRPM8TRPV1HSD11B1
SCHEMBL13056288 0.86 NPY5R (0.51) NPY5RTRPA1SCN9ATRPM8TRPV1
SCHEMBL12999228 0.84 KDM4E (0.48) NPY5RCYP3A4CYP2D6CYP2C19CYP1A2
SCHEMBL12999240 0.83 HSD11B1 (0.42) TRPA1SCN9ATRPM8TRPV1HSD11B1
SCHEMBL12999257 0.82 NPY5R (0.48) NPY5RTRPA1SCN9ATRPM8TRPV1
SCHEMBL12999243 0.82 NPY5R (0.44) NPY5RTRPA1SCN9ATRPM8TRPV1
SCHEMBL3361234 0.81 CYP2A6 (0.44) NPY5RCYP3A4CYP2D6CYP2C19CYP1A2
SCHEMBL13057724 0.81 NPY5R (0.49) NPY5RTRPA1SCN9ASLC22A12SCN5A
SCHEMBL12999261 0.79 NPY5R (0.45) NPY5RTRPA1SCN9ATRPM8TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100308313-A1 Organic Material Containing Oligophenylene Skeleton and Light-Emitting Device Using the Same NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY 2010-12-09 — — US disclosed
EP-2236485-A1 ORGANIC MATERIAL CONTAINING OLIGOPHENYLENE SKELETON AND LIGHT-EMITTING DEVICE USING THE SAME National University Corporation Nagoya University (JP) 2010-10-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100308313-A1 Organic Material Containing Oligophenylene Skeleton and Light-Emitting Device Using the Same BMP2, SOST, BMP4 NPY5R 3234/4885TRPA1 952/4885SCN9A 2897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback